CBFB
MOLECULAR TARGETcore-binding factor subunit beta
CBFB (core-binding factor subunit beta) is targeted by 9 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting CBFB
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | molibresib | 3.81 | 44 |
| 2 | Aurintricarboxylic Acid | 1.10 | 2 |
| 3 | Dihydroxyphenylalanine | 1.10 | 2 |
| 4 | Disulfiram | 1.10 | 2 |
| 5 | Ethidium | 1.10 | 2 |
| 6 | juglone hydroxylase [Supplementary Concept] catalyzes | 1.10 | 2 |
| 7 | Daunorubicin | 0.69 | 1 |
| 8 | Fusaric Acid | 0.69 | 1 |
| 9 | Harmaline | 0.69 | 1 |
About CBFB as a Drug Target
CBFB (core-binding factor subunit beta) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 9 compounds with documented CBFB interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
CBFB inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.